The Smart Investor
    Facebook Instagram
    Tuesday, January 31
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Blue Chips»Should You Accept Cash or Scrip Dividends?
    Blue Chips

    Should You Accept Cash or Scrip Dividends?

    Royston YangBy Royston YangJune 11, 2020Updated:July 13, 20204 Mins Read
    Facebook Twitter LinkedIn Email WhatsApp
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    Every now and then, companies may offer the option for shareholders to select scrip dividends in lieu of cash dividends.

    A scrip dividend offers the shareholder new shares in the company rather than cold, hard cash.

    An example of a blue-chip company that has been offering the option to choose scrip is OCBC Ltd (SGX: O39).

    For its 2019 interim dividend of S$0.25 per share, OCBC issued new shares at S$9.57.

    This offer was a discount of around 9% off the market price of the shares on the date of the announcement (28 August 2019) of S$10.51.

    However, for OCBC’s 2019 final dividend of S$0.28 per share, the scrip dividend option was not available.

    Recently, another blue-chip company, CapitaLand Limited (SGX: C31), proposed a scrip dividend scheme to be applied to its first and final 2019 dividend of S$0.12 per share.

    It was also stated that the issue price of the new scrip shares shall not be set at a discount of more than 10% of the average volume-weighted average price (VWAP) of the shares traded between the ex-dividend date and the dividend record date.

    Raffles Medical Group (SGX: BSL) has also been applying its scrip dividend scheme to both its interim and final dividends, with the final issue price of new shares usually being a 10% discount to the VWAP.

    With the prevalence of such scrip dividend options, should investors select cash or scrip?

    The power of compounding

    By accepting scrip, you will be receiving more shares of the company that you already own.

    Over time, by accepting many rounds of scrip dividends, you can slowly grow your stake in the company.

    These share dividends end up giving you even more dividends over time, allowing the compounding effect to take place.

    Say you start with 1,000 shares and receive scrip dividends of 10 shares. These new shares bump up your total stake to 1,010 shares.

    The following year, the dividends declared by the company will be computed based on the higher level of 1,010 shares, providing you with even more shares should you once again select scrip.

    This compounding effect can be further multiplied if the company declares higher dividends on a year on year basis.

    You will be thus enjoying the best of both worlds — a rising dividend per share, as well as a growing share base with which to calculate your dividends on.

    Benefits of accepting scrip

    There are also several benefits relating to the acceptance of scrip dividends.

    The first is the discount to the VWAP, as mentioned earlier. This discount could be as high as 10% and allows you to receive more shares at a lower computed share price.

    For companies whose share prices stay stubbornly high without falling, accepting the scrip option represents a chance for you to “buy” more shares at lower prices.

    Furthermore, scrip dividends are also credited to one’s account without any transaction fees or brokerage commissions.

    If you had to buy shares from the stock market, brokerage and other fees will be incurred, thus increasing the cost of your purchase.

    Scrip dividends essentially offer both a fuss-free and expenses-free option to increase your stake in your favourite company.

    Get Smart: Check up on the business

    However, we must state an important caveat.

    As an investor, you should check on the health of the business before accepting scrip over cash.

    If the business is in trouble and is issuing scrip dividends to conserve cash, you may wish to think twice about accepting shares.

    This is because you may end up owning more shares of a business that’s worth much less over time.

    For strong, conservatively-financed companies, accepting scrip is a good option for compounding your wealth.

    Want to know what stocks we like for our portfolio? See for yourself now. Simply CLICK HERE to scoop up a FREE copy of our special report. As a bonus, we also highlight 6 blue chips stocks trading at a 10-year low. But you will want to hurry – this free report is available for a brief time only.

    Click here to like and follow us on Facebook and here for our Telegram group.

    Disclaimer: Royston Yang owns shares in Raffles Medical Group Ltd.

    Yahoo
    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    Merger and Acquisition

    What Makes Some Serial Acquirers So Successful

    January 30, 2023
    Data Centre (Sunlight)

    5 Key Takeaways from Mapletree Industrial Trust’s Latest Business Update

    January 30, 2023
    Screen Showing Share Prices

    Get Smart: Why You Shouldn’t Focus on Share Prices Alone

    January 29, 2023
    Facebook Instagram LinkedIn Telegram
    • Careers
    • Disclaimer & Privacy Policy
    • Subscription Terms of Service
    © 2023 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.